Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
“In a major trial, continuous positive airway pressure for obstructive sleep apnea was effective in decreasing the apnea–hypopnea index, improving nocturnal oxygenation, increasing LVEF, lowering norepinephrine levels, and increasing the distance walked in 6 minutes; these benefits were sustained for up to 2 years (394…”
Background2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
“CPAP in HF related CSA has been shown to reduce the frequency of episodes of apnoea and hypopnoea, and improve LVEF and 6 minute walk test distance, but did not improve prognosis or the rate of HF related hospitalizations.(491) The recently published SERVE-HF(473) trial has shown that ASV used in patients with HFrEF a…”
Berry, R. B., Budhiraja, R., Gottlieb, D. J., Gozal, D., Iber, C., Kapur, V. K., Marcus, C. L., Mehra, R., Parthasarathy, S., Quan, S. F., et al. (2012) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.2172 · Cited by 5,302
“89-93 One study defined a hypopnea as obstructive versus central if paradoxical thoracoabdominal excursions were noted or when the reduction in flow was out of proportion to the de - crease in thoracoabdominal excursions (e.g., in central hypopnea the decrease in flow was proportional to the…”
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
“In a major trial, continuous positive airway pressure for obstructive sleep apnea was effective in decreasing the apnea–hypopnea index, improving nocturnal oxygenation, increasing LVEF, lowering norepinephrine levels, and increasing the distance walked in 6 minutes; these benefits were sustained for up to 2 years.(394…”
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Pathophysiology of Sleep Apnea
Dempsey, J. A., Veasey, S. C., Morgan, B. J., & O'Donnell, C. P. (2010) · Physiological Reviews · doi:10.1152/physrev.00043.2008 · Cited by 2,243
“Certainly CPAP clearly prevents airway obstruction in OSA patients; however, it is not tolerated well or at all by some, compliance is low in many others, a residual periodic breathing may ensue in many CPAP users and in some CHF patients CPAP may be contra-indicated (66, 118, 277, 317).”
BackgroundYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
“In a major trial, continuous positive airway pressure for obstructive sleep apnea was effective in decreasing the apnea–hypopnea index, improving nocturnal oxygenation, increasing LVEF, lowering norepinephrine levels, and increasing the distance walked in 6 minutes; these benefits were sustained for up to 2 years (394…”
Sleep Apnea and Cardiovascular Disease
Somers, V. K., White, D. P., Amin, R., Abraham, W. T., Costa, F., Culebras, A., Daniels, S., Floras, J. S., Hunt, C. E., Olson, L. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.002 · Cited by 1,487
“CSA syndrome is present when a patient has 5 central apneas per hour of sleep and the associated symptoms of disrupted sleep (frequent arousals) and/or hypersomnolence during the day.20 Because central apneas also may occur in an individual with obstructive apneas, care must be exercised in deciding that CSA rather th…”
BackgroundInfluentialSelf-citationGoldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189375 · Cited by 1,450
Obstructive sleep apnoea and its cardiovascular consequences
Bradley, T. D., & Floras, J. S. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61622-0 · Cited by 1,385
Self-citationSomers, V. K., White, D. P., Amin, R., Abraham, W. T., Costa, F., Culebras, A., Daniels, S., Floras, J. S., Hunt, C. E., Olson, L. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189420 · Cited by 1,297
Self-citationYoung, T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.8.893 · Cited by 1,304
Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure
Cowie, M. R., Woehrle, H., Wegscheider, K., Angermann, C., d’Ortho, M.-P., Erdmann, E., Levy, P., Simonds, A. K., Somers, V. K., Zannad, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506459 · Cited by 1,107
The Sympathetic Nervous System in Heart Failure
Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.015 · Cited by 978
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.04.014 · Cited by 770
Oldenburg, O., Lamp, B., Faber, L., Teschler, H., Horstkotte, D., & Töpfer, V. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.08.003 · Cited by 756
Insomnia in the Elderly: A Review
Patel, D., Steinberg, J., & Patel, P. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7172 · Cited by 667
Tsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ono, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 704
Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases
Tobaldini, E., Costantino, G., Solbiati, M., Cogliati, C., Kara, T., Nobili, L., & Montano, N. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.07.004 · Cited by 661
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Arzt, M., Floras, J. S., Logan, A. G., Kimoff, R. J., Series, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.683482 · Cited by 669
Self-citationInfluence of Obstructive Sleep Apnea on Mortality in Patients With Heart Failure
Wang, H., Parker, J. D., Newton, G. E., Floras, J. S., Mak, S., Chiu, K.-L., Ruttanaumpawan, P., Tomlinson, G., & Bradley, T. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.046 · Cited by 616
Self-citationEckert, D. J., Jordan, A. S., Merchia, P., & Malhotra, A. (2007) · Chest · doi:10.1378/chest.06.2287 · Cited by 559
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
Mentz, R. J., Kelly, J. P., von Lueder, T. G., Voors, A. A., Lam, C. S. P., Cowie, M. R., Kjeldsen, K., Jankowska, E. A., Atar, D., Butler, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.08.036 · Cited by 546
“The largest randomized, prospective study of HF patients with CSA (N 1⁄4 258) found no survival benefit with CPAP, despite improvements in EF and functional status (110).”
BackgroundSleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science
Drager, L. F., McEvoy, R. D., Barbe, F., Lorenzi-Filho, G., & Redline, S. (2017) · Circulation · doi:10.1161/circulationaha.117.029400 · Cited by 465
Evidence‐Based Recommendations for the Assessment and Management of Sleep Disorders in Older Persons
Bloom, H. G., Ahmed, I., Alessi, C. A., Ancoli‐Israel, S., Buysse, D. J., Kryger, M. H., Phillips, B. A., Thorpy, M. J., Vitiello, M. V., & Zee, P. C. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02220.x · Cited by 464
“Therefore, CPAP is not currently recommended as a first-line treatment in CHF.(119) Small short-term clinical trials have suggested the effectiveness of oxygen and adaptive servoventilation, a ventilatory support mode specifically designed for CHF breathing abnormalities.”
BackgroundInfluentialComplex Sleep Apnea Syndrome: Is It a Unique Clinical Syndrome?
Morgenthaler, T. I., Kagramanov, V., Hanak, V., & Decker, P. A. (2006) · Sleep · doi:10.1093/sleep/29.9.1203 · Cited by 462
Yumino, D., Redolfi, S., Ruttanaumpawan, P., Su, M.-C., Smith, S., Newton, G. E., Mak, S., & Bradley, T. D. (2010) · Circulation · doi:10.1161/circulationaha.109.902452 · Cited by 452
Self-citationJavaheri, S., Shukla, R., Zeigler, H., & Wexler, L. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.084 · Cited by 444
Atherton, J. J., Sindone, A., De Pasquale, C. G., Driscoll, A., MacDonald, P. S., Hopper, I., Kistler, P. M., Briffa, T., Wong, J., Abhayaratna, W., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 431
“There were improvements in exercise capacity, but no improvement in quality of life or hospitalisation rates [448].”
BackgroundThe six‐minute walk test: a useful metric for the cardiopulmonary patient
Rasekaba, T., Lee, A. L., Naughton, M. T., Williams, T. J., & Holland, A. E. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01880.x · Cited by 417
Arnold, J. M. O., Liu, P., Demers, C., Dorian, P., Giannetti, N., Haddad, H., Heckman, G. A., Howlett, J. G., Ignaszewski, A., Johnstone, D. E., et al. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70237-9 · Cited by 415
Lainscak, M., Blue, L., Clark, A. L., Dahlström, U., Dickstein, K., Ekman, I., McDonagh, T., McMurray, J. J., Ryder, M., Stewart, S., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq219 · Cited by 405
“It reduces episodes of apnoea–hypopnoea, the number of arousals, daytime somnolence, and improves the LVEF and quality-of-life.(103) For patients with CSA, it is unclear if there is a role for any treatment.”
BackgroundTietjens, J. R., Claman, D., Kezirian, E. J., De Marco, T., Mirzayan, A., Sadroonri, B., Goldberg, A. N., Long, C., Gerstenfeld, E. P., & Yeghiazarians, Y. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010440 · Cited by 397
“treated with CPAP; however, a post hoc analysis suggested a reduction in mortality among patients for whom CPAP therapy resulted in a significant improvement in AHI (to<15 events/h).(91) While CPAP is effective in relieving obstructive events, many patientswithHF have persistent central apneas and hypopneas despite th…”
MethodSleep Apnea and Cardiovascular Disease: A Bidirectional Relationship
Kasai, T., Floras, J. S., & Bradley, T. D. (2012) · Circulation · doi:10.1161/circulationaha.111.070813 · Cited by 383
Self-citationYu, J., Zhou, Z., McEvoy, R. D., Anderson, C. S., Rodgers, A., Perkovic, V., & Neal, B. (2017) · JAMA · doi:10.1001/jama.2017.7967 · Cited by 371
Aurora, R. N., Chowdhuri, S., Ramar, K., Bista, S. R., Casey, K. R., Lamm, C. I., Kristo, D. A., Mallea, J. M., Rowley, J. A., Zak, R. S., et al. (2012) · Sleep · doi:10.5665/sleep.1580 · Cited by 369
Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep
Randerath, W., Verbraecken, J., Andreas, S., Arzt, M., Bloch, K. E., Brack, T., Buyse, B., De Backer, W., Eckert, D. J., Grote, L., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00959-2016 · Cited by 354
“Bradley et al, 2005 [390] RCT, open label, parallel design 1 N=258 (248 male) HF patients with CSA.”
BackgroundInternational Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Sleep Disordered Breathing and Cardiovascular Disease
Cowie, M. R., Linz, D., Redline, S., Somers, V. K., & Simonds, A. K. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.048 · Cited by 311
Jean-Louis, G., Zizi, F., Clark, L. T., Brown, C. D., & McFarlane, S. I. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27191 · Cited by 305
Diurnal Blood Pressure Pattern and Risk of Congestive Heart Failure
Ingelsson, E., Björklund-Bodegård, K., Lind, L., Ärnlöv, J., & Sundström, J. (2006) · JAMA · doi:10.1001/jama.295.24.2859 · Cited by 295
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 288
Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueño
Lloberes, P., Durán-Cantolla, J., Martínez-García, M. Á., Marín, J. M., Ferrer, A., Corral, J., Masa, J. F., Parra, O., Alonso-Álvarez, M. L., & Terán-Santos, J. (2011) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2011.01.001 · Cited by 247
Aging and Sleep: Physiology and Pathophysiology
Edwards, B., O'Driscoll, D., Ali, A., Jordan, A., Trinder, J., & Malhotra, A. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1265902 · Cited by 245
“While it has been shown to be effective at reducing CSA-CSR in patients with CHF, the largest, randomized, multicenter trial that has been conducted to date did not show improved survival with CPAP use.(156) Because CPAP does not seem to reduce CSA-CSR for a large number of patients with CHF, other forms of treatment…”
Yumino, D., Wang, H., Floras, J. S., Newton, G. E., Mak, S., Ruttanaumpawan, P., Parker, J. D., & Bradley, T. D. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.015 · Cited by 261
Self-citationChai-Coetzer, C. L., Luo, Y.-M., Antic, N. A., Zhang, X.-L., Chen, B.-Y., He, Q.-Y., Heeley, E., Huang, S.-G., Anderson, C., Zhong, N.-S., et al. (2013) · Sleep · doi:10.5665/sleep.3232 · Cited by 246
Chronic Heart Failure: Contemporary Diagnosis and Management
Ramani, G. V., Uber, P. A., & Mehra, M. R. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0494 · Cited by 236
“However, no firm data support improved survival with treatment.(83)”
BackgroundCentral Sleep Apnea and Cheyne-Stokes Respiration
Yumino, D., & Bradley, T. D. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-129mg · Cited by 238
“Treatment of CSR-CSA with either nocturnal oxygen or CPAP lowers SNA both during sleep and wakefulness (15, 65, 77).”
BackgroundMethodInfluentialSelf-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E., Sato, K., Teramoto, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 191
Reframing the Association and Significance of Co-Morbidities in Heart Failure
Triposkiadis, F., Giamouzis, G., Parissis, J., Starling, R. C., Boudoulas, H., Skoularigis, J., Butler, J., & Filippatos, G. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.600 · Cited by 236
Javaheri, S., & Dempsey, J. A. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110057 · Cited by 205
“…along with and a highly sensitive apneic threshold and reduced CO 2 Although treatment of CSA in heart of the scope of this article (19, 70, 111,113, 117, 119, 121, 122, 128, 166, 202, 218), some therapeutic options which give insight into the mechanisms of periodicity and CSA are briefly mentioned.”
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Parati, G., Lombardi, C., Hedner, J., Bonsignore, M. R., Grote, L., Tkacova, R., Lévy, P., Riha, R., Bassetti, C., Narkiewicz, K., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00226711 · Cited by 227
Circadian variation of blood pressure: The basis for the chronotherapy of hypertension
Hermida, R. C., Ayala, D. E., & Portaluppi, F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.08.003 · Cited by 221
Parati, G., Lombardi, C., Hedner, J., Bonsignore, M. R., Grote, L., Tkacova, R., Levy, P., Riha, R., Bassetti, C., Narkiewicz, K., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328350e53b · Cited by 220
Sleep apnea: Clinical investigations in humans
Banno, K., & Kryger, M. H. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.03.003 · Cited by 219
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Lévy, P., Pépin, J.-L., Arnaud, C., Tamisier, R., Borel, J.-C., Dematteis, M., Godin-Ribuot, D., & Ribuot, C. (2008) · European Respiratory Journal · doi:10.1183/09031936.00013308 · Cited by 208
Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients
Maniaci, A., Iannella, G., Cocuzza, S., Vicini, C., Magliulo, G., Ferlito, S., Cammaroto, G., Meccariello, G., De Vito, A., Nicolai, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020277 · Cited by 202
Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial
Costanzo, M. R., Ponikowski, P., Javaheri, S., Augostini, R., Goldberg, L., Holcomb, R., Kao, A., Khayat, R. N., Oldenburg, O., Stellbrink, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30961-8 · Cited by 208
Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor
Floras, J. S. (2018) · Circulation Research · doi:10.1161/circresaha.118.310783 · Cited by 209
“The multicenter CANPAP trial (Canadian Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure) aimed to test the hypothesis that CPAP treatment would improve transplant-free survival of HFrEF patients with CSA.38 During the course of the trial, widespread clinical adoption of β-adrenoceptor and…”
MethodInfluentialSelf-citationJavaheri, S., Caref, E. B., Chen, E., Tong, K. B., & Abraham, W. T. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0406oc · Cited by 207
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Parati, G., Lombardi, C., & Narkiewicz, K. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00400.2007 · Cited by 205
Kasai, T., Usui, Y., Yoshioka, T., Yanagisawa, N., Takata, Y., Narui, K., Yamaguchi, T., Yamashina, A., & Momomura, S.-I. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.868786 · Cited by 201
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Machado, M.-C. L., Vollmer, W. M., Togeiro, S. M., Bilderback, A. L., Oliveira, M.-V. C., Leitão, F. S., Queiroga, F., Lorenzi-Filho, G., & Krishnan, J. A. (2010) · European Respiratory Journal · doi:10.1183/09031936.00192008 · Cited by 197
Sleep-disordered Breathing in Neuromuscular Disease
Aboussouan, L. S. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2224ci · Cited by 186
Advances in Sleep-disordered Breathing
Pack, A. I. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1478oe · Cited by 189
Garrigue, S., Pépin, J.-L., Defaye, P., Murgatroyd, F., Poezevara, Y., Clémenty, J., & Lévy, P. (2007) · Circulation · doi:10.1161/circulationaha.106.659706 · Cited by 191
Morgenthaler, T. I., Gay, P. C., Gordon, N., & Brown, L. K. (2007) · Sleep · doi:10.1093/sleep/30.4.468 · Cited by 188
Jilek, C., Krenn, M., Sebah, D., Obermeier, R., Braune, A., Kehl, V., Schroll, S., Montalvan, S., Riegger, G. A. J., Pfeifer, M., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq183 · Cited by 187
“that at our centre, PAP treatment in CHF patients with SDB was always initiated in hospital under polysomnographic monitoring, which was not mandatory in the CANPAP trial.(22) The present study is subject to several limitations.”
BackgroundMethodSelf-citationThomas, R. J., Mietus, J. E., Peng, C.-K., Gilmartin, G., Daly, R. W., Goldberger, A. L., & Gottlieb, D. J. (2007) · Sleep · doi:10.1093/sleep/30.12.1756 · Cited by 182
Efficacy of Adaptive Servoventilation in Treatment of Complex and Central Sleep Apnea Syndromes
Allam, J. S., Olson, E. J., Gay, P. C., & Morgenthaler, T. I. (2007) · Chest · doi:10.1378/chest.07-1715 · Cited by 184
Eckert, D. J., Malhotra, A., & Jordan, A. S. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.02.003 · Cited by 173
“However, the largest randomized trial to date in patients with heart failure and CSA did not demonstrate a beneficial survival effect of treatment.(80) The efficacy of CPAP in resolving CSA, however, varied dramatically between patients, and a subsequent analysis of these patients revealed a beneficial effect on survi…”
BackgroundVazir, A., Hastings, P. C., Dayer, M., McIntyre, H. F., Henein, M. Y., Poole-Wilson, P. A., Cowie, M. R., Morrell, M. J., & Simonds, A. K. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.08.001 · Cited by 183
“This is in keeping with the criteria used in several other studies [5,16,17].”
MethodResultGooneratne, N. S., Richards, K. C., Joffe, M., Lam, R. W., Pack, F., Staley, B., Dinges, D. F., & Pack, A. I. (2011) · Sleep · doi:10.1093/sleep/34.4.435 · Cited by 174
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease
Elgendy, I. Y., Mahtta, D., & Pepine, C. J. (2019) · Circulation Research · doi:10.1161/circresaha.118.313568 · Cited by 176
Macdonald, M., Fang, J., Pittman, S. D., White, D. P., & Malhotra, A. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27076 · Cited by 177
III Diretriz Brasileira de Insuficiência Cardíaca Crônica
Bocchi, E. A., Marcondes‐Braga, F. G., Ayub‐Ferreira, S. M., Rohde, L. E. P., Junior, W. A. D. O., Almeida, D. R., Moreira, M. D. C. V., Bestetti, R. B., Bordignon, S., Azevedo, C., et al. (2009) · Americanae (AECID Library) · doi:10.1590/s0066-782x2009002000001 · Cited by 170
Effects of Exercise Training in Patients with Chronic Heart Failure and Sleep Apnea
Ueno, L. M., Drager, L. F., Rodrigues, A. C. T., Rondon, M. U. P. B., Braga, A. M. F. W., Mathias, W., Krieger, E. M., Barretto, A. C. P., Middlekauff, H. R., Lorenzi-Filho, G., et al. (2009) · Sleep · doi:10.1093/sleep/32.5.637 · Cited by 167
Heart failure and sleep disorders
on behalf of the Italian Society of Cardiology (SIC) Working Group on Heart Failure members, Parati, G., Lombardi, C., Castagna, F., Mattaliano, P., Filardi, P. P., & Agostoni, P. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.71 · Cited by 165
Adaptive Servoventilation for Treatment of Sleep-Disordered Breathing in Heart Failure
Sharma, B. K., Bakker, J. P., McSharry, D. G., Desai, A. S., Javaheri, S., & Malhotra, A. (2012) · Chest · doi:10.1378/chest.12-0815 · Cited by 163
Sleep-Disordered Breathing: Access Is the Issue
Pack, A. I. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2401008 · Cited by 163
Brack, T., Thüer, I., Clarenbach, C. F., Senn, O., Noll, G., Russi, E. W., & Bloch, K. E. (2007) · Chest · doi:10.1378/chest.07-0121 · Cited by 162
McKelvie, R. S., Moe, G. W. P. L., Cheung, A. W., Costigan, J., Ducharme, A., Estrella-Holder, E., Ezekowitz, J. A., Floras, J. S., Giannetti, N., Grzeslo, A., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.03.011 · Cited by 168
Self-citationObstructive sleep apnea: transition from pathophysiology to an integrative disease model
McNicholas, W. T., & Pevernagie, D. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13616 · Cited by 153
“These mechanisms may also be beneficial in heart failure with CSA and Cheyne-Stokes respiration, as some of these patients are responsive to CPAP treatment (Bradley et al., 2005).”
BackgroundInsomnia Symptoms and Daytime Function in Stable Heart Failure
Redeker, N. S., Jeon, S., Muench, U., Campbell, D., Walsleben, J., & Rapoport, D. M. (2010) · Sleep · doi:10.1093/sleep/33.9.1210 · Cited by 153
Mechanisms and Clinical Consequences of Untreated Central Sleep Apnea in Heart Failure
Costanzo, M. R., Khayat, R., Ponikowski, P., Augostini, R., Stellbrink, C., Mianulli, M., & Abraham, W. T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.025 · Cited by 148
“The CANPAP (Canadian Positive Airway Pressure Trial for Patients with Congestive Heart Failure and Central Sleep Apnea) was performed to better evaluate the potential of CPAP for the treatment of CSA in HF (107).”
MethodCardiovascular Consequences of Sleep Apnea
Selim, B. J., Won, C. H. J., & Yaggi, H. K. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.02.010 · Cited by 163
“Platelets play a key role in ischemic cerebrovascular disease, and increases in platelet aggregability and activation have been demonstrated in patients with sleep apnea,68–73 which improves with CPAP.68,73 The mechanism for increased platelet reactivity in patients with sleep apnea is possibly the cyclic hypoxemia, h…”
BackgroundSleep and Cardiovascular Disease: An Overview
Malhotra, A., & Loscalzo, J. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.10.004 · Cited by 150
Oldenburg, O., Schmidt, A., Lamp, B., Bitter, T., Muntean, B. G., Langer, C., & Horstkotte, D. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.04.007 · Cited by 149
“Sustained and effective heart failure therapy has been shown to reduce the severity of CSA [6–8], but whether treatment of CSA contributes to improvement of cardiac function or prognosis inCHFpatients is still uncertain [3,9,10].”
BackgroundThe Role of Sleep in Cardiovascular Disease
Jaspan, V. N., Greenberg, G. S., Parihar, S., Park, C. M., Somers, V. K., Shapiro, M. D., Lavie, C. J., Virani, S. S., & Slipczuk, L. N. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01207-5 · Cited by 161
“The Canadian CPAP for Patients with CSA and HF (CANPAP) trial, which randomized 258 patients with both CSA and HFrEF on optimal medical therapy for the time period, with an average EF of 24.5%, to CPAP and no CPAP [117].”
MethodInfluentialKhayat, R., Abraham, W., Patt, B., Brinkman, V., Wannemacher, J., Porter, K., & Jarjoura, D. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.05.003 · Cited by 145
“This inpatient testing method has been previously validated against polysomnography (PSG)18 and is accepted for the diagnosis of obstructive sleep apnea (OSA).19 We have validated the sensitivity for OSA of this method in hospitalized heart failure patients as well.12 We also evaluated the predictive value of this inp…”
BackgroundInfluentialDernaika, T. A., Tawk, M. M., Nazir, S. A., Younis, W. G., & Kinasewitz, G. T. (2007) · CHEST Journal · doi:10.1378/chest.06-2562 · Cited by 142
The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease
Framnes, S. N., & Arble, D. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00440 · Cited by 137
The importance of sleep-disordered breathing in cardiovascular disease
Linz, D., Woehrle, H., Bitter, T., Fox, H., Cowie, M., Böhm, M., & Oldenburg, O. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0859-7 · Cited by 150
“Improvements associated with CPAP therapy include a decreased number of CSA episodes, improved oxygenation, increased LVEF, decreased noradrenaline levels and improved 6-min walk distance [96].”
BackgroundDamy, T., Margarit, L., Noroc, A., Bodez, D., Guendouz, S., Boyer, L., Drouot, X., Lamine, A., Paulino, A., Rappeneau, S., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs085 · Cited by 138
“AF, n (%) 22 (27) 23 (22) 22 (18) 13 (27) 9 (15) 2 (10) 14 (33) 9 (27)”
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.